Education
About Us
Working with TipRanks
Follow Us
medmix AG (CH:MEDX)
:MEDX
Total Valuation
medmix AG has a market cap or net worth of CHF449.76M. The enterprise value is CHF732.00M.
Market CapCHF449.76M
Enterprise ValueCHF732.00M
Share Statistics
medmix AG has 41,262,370 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding41,262,370
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
medmix AG’s return on equity (ROE) is -0.02 and return on invested capital (ROIC) is 1.59%.
Return on Equity (ROE)-0.02
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)1.59%
Return on Capital Employed (ROCE)0.02
Revenue Per Employee180.29K
Profits Per Employee-2.38K
Employee Count2,684
Asset Turnover0.51
Inventory Turnover4.30
Valuation Ratios
The current PE Ratio of medmix AG is ―. medmix AG’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.82
Price to FCF0.00
Price to Operating Cash Flow5.92
PEG Ratio―
Income Statement
In the last 12 months, medmix AG had revenue of 483.90M and earned -7.40M in profits. Earnings per share was -0.17.
Revenue483.90M
Gross Profit159.70M
Operating Income12.90M
Pretax Income-6.30M
Net Income-7.40M
EBITDA67.60M
Earnings Per Share (EPS)-0.17
Cash Flow
In the last 12 months, operating cash flow was 86.60M and capital expenditures -38.50M, giving a free cash flow of 48.10M billion.
Operating Cash Flow86.60M
Free Cash Flow48.10M
Free Cash Flow per Share1.17
Dividends & Yields
medmix AG pays an annual dividend of CHF0.5, resulting in a dividend yield of 4.6%
Dividend Per ShareCHF0.5
Dividend Yield4.6%
Payout Ratio64.10%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.94
52-Week Price Change5.12%
50-Day Moving Average11.72
200-Day Moving Average10.37
Relative Strength Index (RSI)35.52
Average Volume (3m)63.37K
Important Dates
medmix AG upcoming earnings date is Feb 26, 2026, TBA (Confirmed).
Last Earnings DateJul 23, 2025
Next Earnings DateFeb 26, 2026
Ex-Dividend DateApr 25, 2025
Financial Position
medmix AG as a current ratio of 1.60, with Debt / Equity ratio of 74.11%
Current Ratio1.60
Quick Ratio1.14
Debt to Market Cap0.72
Net Debt to EBITDA3.36
Interest Coverage Ratio1.07
Taxes
In the past 12 months, medmix AG has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
medmix AG EV to EBITDA ratio is 8.67, with an EV/FCF ratio of 15.38.
EV to Sales1.21
EV to EBITDA8.67
EV to Free Cash Flow15.38
EV to Operating Cash Flow6.77
Balance Sheet
medmix AG has CHF96.20M in cash and marketable securities with CHF323.40M in debt, giving a net cash position of CHF227.20M billion.
Cash & Marketable SecuritiesCHF96.20M
Total DebtCHF323.40M
Net CashCHF227.20M
Net Cash Per ShareCHF5.51
Tangible Book Value Per ShareCHF1.42
Margins
Gross margin is 33.00%, with operating margin of 2.67%, and net profit margin of -1.53%.
Gross Margin33.00%
Operating Margin2.67%
Pretax Margin-1.30%
Net Profit Margin-1.53%
EBITDA Margin13.97%
EBIT Margin1.18%
Analyst Forecast
The average price target for medmix AG is CHF11.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetCHF11.00
Price Target Upside1.10% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast-2.42%
EPS Growth Forecast-222.68%